Yaya Chu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice”.

Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002267

N/A

0DataRank · unranked

41 citations

Gaurav Nayyar, Susiyan Jiang, Jeremy Rosenblum, Patrick Soon‐Shiong, Jeffrey T. Safrit +3 more

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200927

N/A

0DataRank · unranked

10 citations

Meijuan Tian, Uksha Saini, Jessica Ayala-Cuesta, Kayleigh Klose, Alyssa S. Mendelowitz +8 more

Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200820

N/A

0DataRank · unranked

5 citations

Gaurav Nayyar, Meijuan Tian, Dean A. Lee, M. Fevzi Özkaynak, Jessica Ayala-Cuesta +11 more